… disease (PD) develop problems with their ability to walk that can cause serious injuries and curtail their … with a particular genetic modification develop similar locomotor issues and show brain changes akin to those seen in people with PD. We … disease-modifying targets …

… processes, cause familial forms of PD. Understanding how the activity of PINK1 and PRKN in specific cell types changes in response to stress, and how cells’ stress response is altered in the … these studies will serve as potential therapeutic targets for future studies. …

… NEWYORK, NY — As part of its mission to accelerate promising therapeutic targets through the … have been funded by MJFF since 2007 to identify lead compounds that could prevent the death of dopamine-producing … (FDA) (or other regulatory agency) that also show potential to benefit Parkinson’s patients. Such drugs’ …

… in the brain. Several small soluble proteins that are commonly secreted during inflammatory responses have been found elevated in cerebrospinal … the major inflammatory cells in the brain, have been shown to contain neuron-derived neuromelanin presumably by a …

… take the shame out of having Parkinson’s. There used to be a lot of shame, for whatever reason, around having … for him and an inspirational moment for the Parkinson’s community worldwide.    “Despite his physical difficulties, … — I said I need to see where this fits in my world and see how I can use it. And that’s what I’ve done,” Michael said. …

… Michael J. Fox Foundation for Parkinson’s Research (MJFF) today celebrates the passage of The National Plan to End … we could only dream of the breakthroughs the Parkinson’s community has experienced over the last year, from the … endlessly thankful to everyone who has carried the load to get us here — advocates, scientists, patients, families, …